Transactions
CorMedix, Inc.’s convertible debt financing in conjunction with the acquisition of Melinta Therapeutics, LLC
Date Announced:
08/07/2025
client:
CorMedix, Inc.
Status:
Closed – 08/07/2025
Value:
$150 million
Date Announced:
08/07/2025
client:
CorMedix, Inc.
Status:
Closed – 08/07/2025
Value:
$150 million
